BF2.649 (pitolisant)

DRUG2 trials

Sponsors

Bioprojet

Conditions

Parkinson's Disease

Phase 3

Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

CompletedNCT01036139

BioprojetParkinson's Disease

Start: 2009-12-31End: 2012-08-31Updated: 2013-04-12

Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

CompletedNCT01066442

BioprojetParkinson's Disease

Start: 2010-03-31End: 2012-08-31Updated: 2013-04-12